Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : biotech litigation

Soleno Therapeutics Lawsuit Over Misleading DCCR Trial Claims

Soleno Therapeutics Lawsuit Over Misleading DCCR Trial Claims
03/23/2026 | Companies
The Schall Law Firm, a nationwide firm focused on shareholder rights litigation, is alerting investors to a class action lawsuit filed against Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO). The suit alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act...
adverse events risk, biotech litigation, class action case, class period disclosure, DCCR clinical trial, diazoxide choline extended release, drug safety concerns, financial damages, investor losses, misleading statements, Phase 3 trial risks, securities fraud allegations, shareholder lawsuit, Soleno Therapeutics lawsuit, stock market litigation

Soleno Therapeutics SLNO Securities Fraud Class Action Lawsuit Update

Soleno Therapeutics SLNO Securities Fraud Class Action Lawsuit Update
03/18/2026 | Companies
Kahn Swick & Foti, LLC (“KSF”), along with its partner and former Louisiana Attorney General, Charles C. Foti, Jr., is alerting investors of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) about a filed securities class action lawsuit. Class Definition: The lawsuit aims to recover...
biotech litigation, Charles C Foti Jr, class action lawsuit, clinical trial controversy, DCCR drug, financial losses, investor lawsuit, investor rights, Kahn Swick & Foti, lead plaintiff deadline May 2026, legal claim, Lewis Kahn, NasdaqCM SLNO, pharmaceutical risk disclosure, Prader Willi syndrome, securities class action, securities fraud allegations, shareholder lawsuit, SLNO, Soleno Therapeutics, stock fraud


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com